Literature DB >> 15749729

Role of reactive oxygen species and p38 MAPK in the induction of the pro-adhesive endothelial state mediated by IgG from patients with anti-phospholipid syndrome.

Stéphanie Simoncini1, Cédric Sapet, Laurence Camoin-Jau, Nathalie Bardin, Jean-Robert Harlé, José Sampol, Françoise Dignat-George, Francine Anfosso.   

Abstract

The association of the presence of anti-phospholipid antibodies (aPL) with thrombosis characterizes the anti-phospholipid syndrome (APS). The activation of the endothelium is a key event in the establishment of the thrombophilic state. However, the intracellular mechanisms leading to endothelial dysfunction are not fully elucidated. We investigated the role of reactive oxygen species (ROS) in the pro-adhesive state elicited by aPL and studied ROS-dependent downstream signaling pathways. Independent incubation of human umbilical vein endothelial cells (HUVEC) with IgG (IgG-APS) from 12 APS patients caused a large and sustained increase in ROS, which was prevented by the antioxidants vitamin C and N-acetyl-L-cysteine. ROS inhibition observed in the presence of diphenylene iodonium and rotenone indicated an involvement of a membrane-bound oxidase and the mitochondrial transport chain as sources of ROS. ROS acted as a second messenger by activating the p38 mitogen-activated protein kinase and its subsequent target, the stress-related transcription factor activating transcription factor-2 (ATF-2). ROS controlled the up-regulation of vascular cell adhesion molecule-1 expression by IgG-APS-stimulated HUVEC and the increase in THP-1 monocytic cells adhesion. The IgG-APS-mediated oxidative stress was observed irrespective of the clinical and biological criterions of the patients studied here. Taken together, these data indicate that the oxidative stress induced by IgG-APS is a key intracellular event that might contribute to the thrombotic complications of APS by controlling the endothelial adhesive phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15749729     DOI: 10.1093/intimm/dxh229

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  10 in total

Review 1.  Auto-antibodies as emergent prognostic markers and possible mediators of ischemic cardiovascular diseases.

Authors:  P Roux-Lombard; S Pagano; F Montecucco; N Satta; N Vuilleumier
Journal:  Clin Rev Allergy Immunol       Date:  2013-02       Impact factor: 8.667

Review 2.  The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.

Authors:  Rohan Willis; E B Gonzalez; A R Brasier
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

Review 3.  Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis.

Authors:  Chieko Mineo
Journal:  Curr Rheumatol Rep       Date:  2013-05       Impact factor: 4.592

Review 4.  Mechanisms of aPL-mediated thrombosis: effects of aPL on endothelium and platelets.

Authors:  Mariano E Vega-Ostertag; Silvia S Pierangeli
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

5.  Aliskiren prevents the toxic effects of peritoneal dialysis fluids during chronic dialysis in rats.

Authors:  Juan Pérez-Martínez; Francisco C Pérez-Martínez; Blanca Carrión; Jesús Masiá; Agustín Ortega; Esther Simarro; Syong H Nam-Cha; Valentín Ceña
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

6.  Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin.

Authors:  Miyuki Bohgaki; Masaki Matsumoto; Tatsuya Atsumi; Takeshi Kondo; Shinsuke Yasuda; Tetsuya Horita; Keiichi I Nakayama; Fumihiko Okumura; Shigetsugu Hatakeyama; Takao Koike
Journal:  J Cell Mol Med       Date:  2011-01       Impact factor: 5.310

Review 7.  Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone).

Authors:  Tomomi Masuda; Masamitsu Shimazawa; Hideaki Hara
Journal:  Oxid Med Cell Longev       Date:  2017-01-18       Impact factor: 6.543

8.  Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome.

Authors:  Manuela Velásquez; Luisa F Peláez; Mauricio Rojas; Raúl Narváez-Sánchez; Jesús A Velásquez; Carlos Escudero; Sebastián San Martín; Ángela P Cadavid
Journal:  Front Physiol       Date:  2021-12-02       Impact factor: 4.566

Review 9.  The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System.

Authors:  R Arreola-Diaz; A Majluf-Cruz; L E Sanchez-Torres; J Hernandez-Juarez
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

10.  Oxidative stress in endothelial cells induced by the serum of women with different clinical manifestations of the antiphospholipid syndrome

Authors:  Manuela Velásquez; Manuel Alejandro Granada; Juan Camilo Galvis; Ángela María Álvarez; Ángela Cadavid
Journal:  Biomedica       Date:  2019-12-01       Impact factor: 0.935

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.